Date | Time | Place | Session / Title | Role |
April 29 | 7:00 AM - 8:10 AM | Presentation Theater 2, Level 1 | Valves | Moderator |
April 29 | 7:42 AM - 7:50 AM | Presentation Theater 2, Level 1 | Valves Case 1: TAVR for Pure AR - Indication and Device |
Lecturer |
April 29 | 8:30 AM - 9:45 AM | Presentation Theater 1, Level 1 | Spotlights of Major Clinical Studies with Expert Commentary | Discussant |
April 29 | 8:38 AM - 8:45 AM | Presentation Theater 1, Level 1 | Spotlights of Major Clinical Studies with Expert Commentary Discussion: Deep Dive into Mitraclip Trials for Functional MR |
Discussant |
April 29 | 9:08 AM - 9:15 AM | Presentation Theater 1, Level 1 | Spotlights of Major Clinical Studies with Expert Commentary Discussion: Evidence-based Optimal Bypass Surgery |
Discussant |
April 29 | 10:50 AM - 11:40 AM | Case Zone II, Level 1 | 2-9. Structural Heart Disease | Moderator |
April 29 | 2:00 PM - 4:00 PM | Presentation Theater 1, Level 1 | Valves | Panelist |
April 29 | 3:34 PM - 3:42 PM | Presentation Theater 1, Level 1 | Valves Transcatheter Mitral Valve Replacement: Current Evidence and Experience |
Lecturer |
April 29 | 4:30 PM - 4:50 PM | Interview Lounge, Level 2 | Valve | Interviewee |
April 30 | 8:35 AM - 10:20 AM | Structural Heart & Endovascular Theater, Level 1 | Live Case & Lecture Session I | Discussant |